What is ClickDiagnostics?
ClickDiagnostics is a health technology company founded in May 2008, dedicated to leveraging mobile phone technology to address critical healthcare challenges. The company's core premise is to make health services ubiquitous by connecting public health infrastructure, enabling remote patient data collection, and facilitating remote diagnosis. ClickDiagnostics has implemented its mobile tele-consultation platform across Africa, South Asia, and the Americas, providing access to quality medical treatment in underserved areas. Concurrently, it collaborates with health organizations, governments, and NGOs to gather real-time health data for effective interventions. The platform also includes medical record analysis features to aid doctors in providing accurate diagnoses and treatment advice.
How much funding has ClickDiagnostics raised?
ClickDiagnostics has raised a total of $196.3M across 4 funding rounds:
Series A
$16M
Debt
$9.5M
Series B
$100.8M
Series C
$70M
Series A (2015): $16M, investors not publicly disclosed
Debt (2018): $9.5M, investors not publicly disclosed
Series B (2020): $100.8M, investors not publicly disclosed
Series C (2020): $70M featuring Cedars-Sinai, John Doerr, and Pitango Venture Capital
Key Investors in ClickDiagnostics
Cedars-Sinai
Cedars-Sinai, a renowned non-profit academic medical center founded in 1902, offers a wide spectrum of clinical programs and is dedicated to improving community health, particularly for vulnerable populations.
Pitango Venture Capital
Pitango Venture Capital is a leading venture capital firm that supports visionary entrepreneurs and groundbreaking companies across various sectors, including technology and health, from inception to maturity.
John Doerr
John Doerr is a prominent figure in the venture capital landscape, known for his investments in transformative technology companies.
What's next for ClickDiagnostics?
The recent major strategic investment signals a new phase of growth and scaling for ClickDiagnostics. With a robust history of implementing mobile health solutions in diverse global markets, the company is well-positioned to further enhance its reach and impact. This capital will likely fuel product development, expand service offerings, and strengthen strategic partnerships. The focus on enterprise-level funding suggests an ambition to solidify its market leadership and potentially explore new technological integrations to further revolutionize remote healthcare delivery.
See full ClickDiagnostics company page
